Inhibrx Vs. Outlook Therapeutics Industry Stock Comparison

Buy

54

INBX
Inhibrx

Last Price:

34.16

Seasonality Move:

13.94%

Sell

49

OTLK
Outlook Therapeutics

Last Price:

8.57

Seasonality Move:

23.21%

Buy

54

Inhibrx (INBX) is a Buy

Is Inhibrx a Buy, Sell or Hold?

The current Inhibrx [INBX] share price is $34.15. The Score for INBX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
INBX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Sell

49

Outlook Therapeutics (OTLK) is a Sell

Is Outlook Therapeutics a Buy, Sell or Hold?

The current Outlook Therapeutics [OTLK] share price is $8.60. The Score for OTLK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
OTLK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INBX Stock Price Chart

What is Inhibrx's stock price today?

The Inhibrx share price today is $34.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX is experiencing slight selling pressure.

OTLK Stock Price Chart

What is Outlook Therapeutics's stock price today?

The Outlook Therapeutics share price today is $8.60
The current trend is moderately bearish and OTLK is experiencing selling pressure, which indicates risk of future bearish movement.

INBX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.3	Sell
Relative Strength Index (14 RSI):	41.15	Sell
Chaikin Money Flow:	-8503	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(34.16 - 34.9)	Sell
Bollinger Bands (100):	(32.2 - 37.98)	Sell

OTLK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.02	Sell
Relative Strength Index (14 RSI):	50	Buy
Chaikin Money Flow:	-54108	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(8.28 - 9.36)	Sell
Bollinger Bands (100):	(7.47 - 9.13)	Buy

INBX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	34.15	Buy
20-day SMA:	34.44	Sell
50-day SMA:	35.17	Sell
200-day SMA:	27.27	Buy
8-day EMA:	34.17	Sell
20-day EMA:	34.41	Sell
50-day EMA:	34.68	Sell
200-day EMA:	30.02	Buy

OTLK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	8.56	Buy
20-day SMA:	8.63	Sell
50-day SMA:	8.49	Buy
200-day SMA:	11.15	Sell
8-day EMA:	8.58	Buy
20-day EMA:	8.6	Sell
50-day EMA:	8.56	Buy
200-day EMA:	11.71	Sell

Inhibrx Earnings Growth & INBX Earnings Dates

Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.51 per share, and a decrease next year of $0.10 per share.

Outlook Therapeutics Earnings Growth & OTLK Earnings Dates

Analysts estimate an earnings increase this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.24 per share, and an increase next year of $1.59 per share.

Inhibrx Technical Analysis

	Apr 22	Apr 23	Apr 24	Apr 25	Apr 26	Apr 29	Apr 30	May 1	May 2	May 3
	Apr								May
	22	23	24	25	26	29	30	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Outlook Therapeutics Technical Analysis

	Apr 22	Apr 23	Apr 24	Apr 25	Apr 26	Apr 29	Apr 30	May 1	May 2	May 3
	Apr								May
	22	23	24	25	26	29	30	01	02	03
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):